NEW YORK (Reuters Health) – Some modulators of 5-hydroxytryptamine (5-HT) appear to be effective in relieving symptoms of irritable bowel syndrome (IBS), the results of a systematic review…
Robert Shorr, Ph.D, D.I.C, Chief Executive Officer of Cornerstone Pharmaceuticals, talks about his company’s approach to the treatment of cancer by targeting and exploiting specific metabolic pathways with…
NEW YORK (Reuters Health) – Information from previous colonoscopies may help identify low-risk polypectomy patients who are unlikely to benefit from intense surveillance, a large prospective cohort study…
NEW YORK (Reuters Health) – New research indicates that survival is similar for smokers and non-smokers who undergo liver transplantation. At least one large insurance company is denying…
NEW YORK (Reuters Health) – Although capsule endoscopy (PillCam COLON Capsule; Given Imaging) provides visualization of the colonic mucosa, it is not as sensitive as standard colonoscopy for…
A new tool in the fight against Barrett’s Esophagus shows promise. A recent study by Dr. Nicholas Shaheen, director of the University of North Carolina Center for Functional…
NEW YORK (Reuters Health) – Proton pump inhibitor therapy can induce acid-related symptoms in healthy adults after drug withdrawal, according to the results of a randomized, placebo-controlled study…
NEW YORK (Reuters Health) – Celiac disease is 4 times more common now than it was in the 1950’s, according to researchers at the Mayo Clinic in Rochester,…
Barry Marshall, MD, AC, FRS, FAA, discusses the possibilities of making a swine flu vaccine using helicobacter as a vaccine delivery platform and the progress made so far…
Barry Marshall, MD, AC, FRS, FAA, describes his discovery of helicobacter pylori as a cause of peptic ulcer disease and what it felt like to win a Nobel…